Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03556384
Title Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Adam Burgoyne, MD, PhD
Indications

gastrointestinal stromal tumor

Therapies

Temozolomide

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center Recruiting La Jolla California 92093 United States Details
University of Miami Recruiting Miami Florida 33136 United States Details
Dana-Farber Cancer Institute Not yet recruiting Boston Massachusetts 02215 United States Details
Oregon Health & Science University Recruiting Portland Oregon 97239 United States Details
Fox Chase Cancer Center Recruiting Philadelphia Pennsylvania 19111 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field